NASDAQ:AEZS • CA0079756007
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AETERNA ZENTARIS INC (AEZS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2021-10-25 | HC Wainwright & Co. | Initiate | Buy |
| 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 5.3M 43.24% | 5.6M 5.66% | 4.498M -19.68% | 4.386M -2.49% | |
| EBITDA YoY % growth | -8.55M -45.66% | -15.06M -76.14% | -17.839M -18.45% | N/A | |
| EBIT YoY % growth | -8.7M -42.62% | -15.2M -74.71% | -18.008M -18.47% | -17.22M 4.38% | |
| Operating Margin | -164.15% | -271.43% | -400.36% | -392.60% | |
| EPS YoY % growth | N/A -8,623.91% | -2.94 51.96% | -11.00 -274.15% | -3.44 68.75% |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.84 59.79% | -0.89 73.90% | -0.89 80.88% |
| Revenue Q2Q % growth | 1.122M -50.04% | 1.122M 37,300.00% | 1.122M 827.27% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A |
All data in USD
AETERNA ZENTARIS INC (AEZS) will report earnings on 2024-11-07, before the market open.
The consensus EPS estimate for the next earnings of AETERNA ZENTARIS INC (AEZS) is -0.84 USD and the consensus revenue estimate is 1.12M USD.
The consensus rating for AETERNA ZENTARIS INC (AEZS) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.